Compensation in the "hundreds of millions" would solve a few headaches Pharma is a $80B company so I think they can spare it for a few poverty stricken lawyers
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress